Tuesday, July 17, 2018

Indivior Plc's shares jumped more than 33 percent on Monday after a U.S. court blocked a rival from selling a cheaper copycat of the British drugmaker's bestselling opioid addiction treatment.


from Reuters: Health News https://ift.tt/2uDEczr

Related Posts:

  • LATEST HEALTH NEWSExpress Scripts Holding Co, one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, but exclude a rival medication from Teva Pharmaceutical Industries Ltd after pric… Read More
  • LATEST HEALTH NEWSA respected science journal is to withdraw a much-cited review of evidence on an illness known as chronic fatigue syndrome (CFS) amid fierce criticism and pressure from activists and patients. from Reuters: Health News h… Read More
  • LATEST HEALTH NEWSExpress Scripts Holding Co, one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, but exclude a rival medication from Teva Pharmaceutical Industries Ltd after pric… Read More
  • LATEST HEALTH NEWS(Reuters Health) - An HIV-prevention drug pill, dubbed PrEP, dramatically reduced new infections in a large group of high risk gay men, Australian researchers report. from Reuters: Health News https://ift.tt/2RWwknB … Read More
  • LATEST HEALTH NEWS(Reuters Health) - For people with diabetes, the chance of developing eye damage that can lead to blindness may depend on how many hours per day they can keep their blood sugar levels under control, a Chinese study suggests. … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner